Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been ...

LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk is under pressure from investors for more information about its next-generation ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

Investigators have recovered the cockpit voice recorder of a medical transport jet that crashed Jan. 31 in Philadelphia, ...

The project is just days away from its official debut. (Feb. 4, 2025) ...

Chicago Teachers Union will hold "walk-ins" at several schools Tuesday morning. Florida State Seminoles face the Notre Dame Fighting Irish on 4-gam... A young Wisconsin man died from an asthma ...

The new Celebrity Xcel cruise ship feature The Bazaar, a new first of its kind multi-level and multi-sensory concept.

Get dialed in every Tuesday & Friday with quick updates on the world of crypto ...